Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies-Reference-Cited by-同舟云学术

Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies

Published:2018-09-17 Issue:10 Volume:9 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Rosati Jessica^ORCID,Ferrari Daniela,Altieri Filomena,Tardivo Silvia,Ricciolini Claudia,Fusilli Caterina^ORCID,Zalfa Cristina,Profico Daniela C.,Pinos Francesca,Bernardini Laura,Torres Barbara,Manni Isabella,Piaggio Giulia^ORCID,Binda Elena,Copetti Massimiliano,Lamorte Giuseppe,Mazza Tommaso^ORCID,Carella Massimo,Gelati Maurizio,Valente Enza Maria,Simeone Antonio,Vescovi Angelo L.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-018-0990-2.pdf

Reference65 articles.

1. Li, W. et al. Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proc. Natl Acad. Sci. USA 113, 6544–6549 (2016).

2. Lysaght, T., Kerridge, I. H., Sipp, D., Porter, G. & Capps, B. J. Ethical and regulatory challenges with autologous adult stem cells: a comparative review of international regulations. J. Bioeth. Inq. 14, 261–273 (2017).

3. Kimmelman, J. et al. New ISSCR guidelines: clinical translation of stem cell research. Lancet 387, 1979–1981 (2016).

4. Irion, S., Zabierowski, S. E. & Tomishima, M. J. Bringing neural cell therapies to the clinic: past and future strategies. Mol. Ther. Methods Clin. Dev. 4, 72–82 (2017).

5. Bjorklund, A. & Kordower, J. H. Cell therapy for Parkinson’s disease: what next? Mov. Disord. 28, 110–115 (2013).

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid and accurate identification of stem cell differentiation stages via SERS and convolutional neural networks;Biomedical Optics Express;2024-04-02

2. Label-Free and High-Throughput Removal of Residual Undifferentiated Cells From iPSC-Derived Spinal Cord Progenitor Cells;Stem Cells Translational Medicine;2024-02-07

3. Roles of Ipsc in Advancing Treatments for Neurological Disorders;2024

4. Neural stem cell therapies for spinal cord injury repair: an update on recent preclinical and clinical advances;Brain;2023-11-17

5. 3D chitosan scaffolds support expansion of human neural stem cells in chemically defined condition;Matter;2023-10